02415 MEDSCI
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 6.73X | Oper Margin | 7.3% |
|---|---|---|---|
| LT Debt/Equity | 0.3% | Net Margin | 6.6% |
| Total Debt/Equity | 0.5% | Return on Equity | 1.5% |
| Price/Book | 0.57X | Return on Assets | 1.3% |
| (HKD 1.230) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 19.97 | 26.55 | 60.67 | -111.99 | -184.72 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -24.8 | -56.2 | +154.2 | +39.4 | -638.3 |
| Earnings Per Share (HKD) | 0.037 | 0.049 | 0.117 | -0.237 | -21.572 |
| Earnings Per Share Growth (%) | -25.7 | -58.1 | +149.4 | +98.9 | -700.5 |
| Dividend Per Share (HKD) | 0.011 | No dividend | No dividend | No dividend | No dividend |
| P/E* (X) | 33.70 | 25.05 | 10.50 | N/A | N/A |
| Yield (%) | 0.89 | N/A | N/A | N/A | N/A |
| Dividend Share (%) | 30.14 | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 2.165 | 2.049 | 2.034 | N/A | N/A |
| Auditors' Opinion | N/A | Unqualified | Unqualified | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 270.374 | 260.623 | +3.7 | 349.194 |
| Operating Result | 19.524 | 25.497 | -23.4 | 60.45 |
| Profit Before Taxation | 19.524 | 25.497 | -23.4 | 60.45 |
| Taxation | 1.587 | 0.53 | +199.4 | 5.408 |
| Profit /( Loss) After Taxation | 17.937 | 24.967 | -28.2 | 55.042 |
| Net Profit | 17.937 | 24.967 | -28.2 | 55.042 |
| Earnings Per Share () | 0.0365 | 0.0491 | -25.7 | 0.1171 |
| Dividend Per Share () | 0.0110 | 0.0000 | N/A | 0.0000 |
| Announcement Date | 2026-03-31 | 2025-03-28 | NA | 2024-03-28 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
